9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma

NCT04832438 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Replaced by NCT05010629

Conditions

Salivary Gland Carcinoma
Adenoid Cystic Carcinoma
Salivary Gland Cancer
Salivary Gland Neoplasms

Interventions

DRUG: 9-ING-41
DRUG: Carboplatin

Sponsor

Actuate Therapeutics Inc.